Recombinant Human Tumor Necrosis Factor-? Receptor?:IgG Fc Fusion...

ha aggiunto una foto Altre informazioni

2026-05-07 09:31:24 -

Recombinant Human Tumor Necrosis Factor-? Receptor?:IgG Fc Fusion Protein for Injection Market Future Scope and Regional Analysis Showing CAGR of 7.8% Between 2026-2034

According to a new report from Intel Market Research, the global Recombinant Human Tumor Necrosis Factor-α Receptor:IgG Fc Fusion Protein for Injection market was valued at USD 1.45 billion in 2025 and is projected to reach USD 2.87 billion by 2034, growing at a robust CAGR of 7.8% during the forecast period (2026–2034). This growth is propelled by the increasing prevalence of...

0 Commenti 0 condivisioni 3 Views